Characterization and comparison of 5 platelet-rich plasma preparations in a single-donor model
- PMID: 24725317
- DOI: 10.1016/j.arthro.2014.02.020
Characterization and comparison of 5 platelet-rich plasma preparations in a single-donor model
Abstract
Purpose: The purpose of this study was to compare the biological characteristics of platelet-rich plasma (PRP) obtained from 4 medical devices and a preparation developed in our laboratory using a single-donor model.
Methods: Ten healthy persons donated blood that was processed to produce PRP by use of 4 commercial preparation systems and a protocol developed in our laboratory. Volumes and platelet, white blood cell (WBC), and red blood cell concentrations were recorded. The platelet activation status was assessed by flow cytometry. Enzyme-linked immunosorbent assay was used to determine the concentrations of vascular endothelial growth factor, platelet-derived growth factor AB, epidermal growth factor, and transforming growth factor β1. We calculated platelet capture efficiency, relative composition, and increase factors from whole blood in platelets and WBC, as well as platelet and growth factor (GF) doses, provided from each preparation.
Results: Leukocyte-rich PRP was obtained with RegenPRP (RegenLab, Le Mont-sur-Lausanne, Switzerland) and the Mini GPS III System (Biomet Biology, Warsaw, IN) and provides PRP with higher proportions of red blood cells, WBCs, and neutrophils than leukocyte-poor PRP obtained with the Selphyl System (Selphyl, Bethlehem, PA), Arthrex ACP (Arthrex, Naples, FL), and the preparation developed in our laboratory. The highest platelet and GF concentrations and doses were obtained with the Mini GPS III System and the preparation developed in our laboratory. Different centrifugation protocols did not show differences in the percentages of activated platelets. Finally, a positive correlation between platelet doses and all the GFs studied was found, whereas a positive correlation between WBC doses and GFs was found only for vascular endothelial growth factor and epidermal growth factor.
Conclusions: In a single-donor model, significant biological variations in PRP obtained from different preparation systems were highlighted. The observed differences suggest different results for treated tissue and could explain the large variability in the clinical benefit of PRP reported in the literature.
Clinical relevance: Our findings will help clinicians to choose a system that meets their specific needs for a given indication.
Copyright © 2014 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Comparison of the Cellular Composition and Cytokine-Release Kinetics of Various Platelet-Rich Plasma Preparations.Am J Sports Med. 2015 Dec;43(12):3062-70. doi: 10.1177/0363546515608481. Epub 2015 Oct 15. Am J Sports Med. 2015. PMID: 26473014
-
Effects of Aspirin on Growth Factor Release From Freshly Isolated Leukocyte-Rich Platelet-Rich Plasma in Healthy Men: A Prospective Fixed-Sequence Controlled Laboratory Study.Am J Sports Med. 2019 Apr;47(5):1223-1229. doi: 10.1177/0363546519827294. Epub 2019 Mar 19. Am J Sports Med. 2019. PMID: 30888847
-
Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma.Am J Sports Med. 2011 Oct;39(10):2135-40. doi: 10.1177/0363546511417792. Epub 2011 Aug 16. Am J Sports Med. 2011. PMID: 21846925
-
Concentrations of Blood Components in Commercial Platelet-Rich Plasma Separation Systems: A Review of the Literature.Am J Sports Med. 2019 Feb;47(2):479-487. doi: 10.1177/0363546517746112. Epub 2018 Jan 16. Am J Sports Med. 2019. PMID: 29337592 Review.
-
Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF).Curr Pharm Biotechnol. 2012 Jun;13(7):1145-52. doi: 10.2174/138920112800624382. Curr Pharm Biotechnol. 2012. PMID: 21740377 Review.
Cited by
-
Clinical Outcome of Multiple Platelet-Rich Plasma Injection and Correlation with PDGF-BB in the Treatment of Knee Osteoarthritis.J Pers Med. 2024 Feb 7;14(2):183. doi: 10.3390/jpm14020183. J Pers Med. 2024. PMID: 38392616 Free PMC article.
-
A review of platelet-rich plasma for enteric fistula management.Front Bioeng Biotechnol. 2023 Nov 15;11:1287890. doi: 10.3389/fbioe.2023.1287890. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 38033816 Free PMC article. Review.
-
Optimizing Platelet-Rich Plasma: Spin Time and Sample Source.Bioengineering (Basel). 2023 Oct 31;10(11):1270. doi: 10.3390/bioengineering10111270. Bioengineering (Basel). 2023. PMID: 38002394 Free PMC article.
-
Factors affecting the features of platelet-rich plasma in patients with knee osteoarthritis.Acta Orthop Traumatol Turc. 2023 Jul;57(4):148-153. doi: 10.5152/j.aott.2023.22077. Acta Orthop Traumatol Turc. 2023. PMID: 37670448 Free PMC article.
-
Impact of Biologic Augmentation on Revision Surgery Rates After Meniscus Repair: A Matched-Cohort Analysis of 3420 Patients.Orthop J Sports Med. 2023 Aug 25;11(8):23259671231186990. doi: 10.1177/23259671231186990. eCollection 2023 Aug. Orthop J Sports Med. 2023. PMID: 37655247 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
